Evaluation of tissue-engineered human acellular vessels as a Blalock–Taussig–Thomas shunt in a juvenile primate model

OBJECTIVES: Palliative treatment of cyanotic congenital heart disease (CCHD) uses systemic-to-pulmonary conduits, often a modified Blalock–Taussig–Thomas shunt (mBTTs). Expanded polytetrafluoroethylene (ePTFE) mBTTs have associated risks for thrombosis and infection. The Human Acellular Vessel (HAV)...

Descripción completa

Detalles Bibliográficos
Autores principales: Nash, Kevin M., Boe, Brian A., Carrillo, Sergio A., Harrison, Andrew, Iwaki, Ryuma, Kelly, John, Kirkton, Robert D., Krishnamurthy, Ramkumar, Lawson, Jeffrey H., Matsuzaki, Yuichi, Prichard, Heather L., Shah, Kejal, Shinoka, Toshiharu, Breuer, Christopher K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Congenital: Pulmonary Artery: Basic Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556952/
https://www.ncbi.nlm.nih.gov/pubmed/37808023
http://dx.doi.org/10.1016/j.xjon.2023.05.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556952/
https://www.ncbi.nlm.nih.gov/pubmed/37808023
http://dx.doi.org/10.1016/j.xjon.2023.05.018

Ejemplares similares